2018
DOI: 10.1016/j.jpedsurg.2018.02.084
|View full text |Cite
|
Sign up to set email alerts
|

Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
11
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 29 publications
0
11
0
Order By: Relevance
“…In addition, ileal mRNA and protein levels of occludin and claudin-3 and jejunum mRNA and protein levels of claudin-3 were reduced by EGF treatment to dam fed control levels and occludin and claudin-3 in the ileum were redistributed towards the apical and basolateral membranes along the crypt-villus axis contributing to a functional TJ barrier [137]. JAM-A and ZO-1 were more markedly/sharply expressed on immunofluorescence pictures following oral recombinant EGF from soybean administration, probably indicating better incorporation in TJ complexes of these proteins [104]. Enteral EGF treatment of NEC protocol exposed mice also significantly increased the number of goblet cells (Muc2) in the ileum and thickened the villus mucus layer compared to both NEC protocol exposed and control mice [137].…”
Section: Hormone Growth Factor or Vitamin-based Feeding Interventionsmentioning
confidence: 98%
See 4 more Smart Citations
“…In addition, ileal mRNA and protein levels of occludin and claudin-3 and jejunum mRNA and protein levels of claudin-3 were reduced by EGF treatment to dam fed control levels and occludin and claudin-3 in the ileum were redistributed towards the apical and basolateral membranes along the crypt-villus axis contributing to a functional TJ barrier [137]. JAM-A and ZO-1 were more markedly/sharply expressed on immunofluorescence pictures following oral recombinant EGF from soybean administration, probably indicating better incorporation in TJ complexes of these proteins [104]. Enteral EGF treatment of NEC protocol exposed mice also significantly increased the number of goblet cells (Muc2) in the ileum and thickened the villus mucus layer compared to both NEC protocol exposed and control mice [137].…”
Section: Hormone Growth Factor or Vitamin-based Feeding Interventionsmentioning
confidence: 98%
“…Fish oil (rich in n-3 PUFA) [82,83] MPL [84] MFGM [48] Very low fat diet [85] Reduced long chain triacylglycerol diet (considered pre-digested) [85] Pomegranate seed oil [47] Carbohydrate/sugar-based interventions HMO [38,42,49,[86][87][88][89][90] Neutral HMO (no sialic acids) [42] −2 HMO (two sialic acids) [42] DSLNT (HMO) [42] DSLNnT (synthetic disialyl glycan) [89,90] DS'LNnT (synthetic disialyl glycan) [89,90] 2 -FL [87,91,92] 6 -SL [92] 2 -FL and 6 -SL [42,92] Sialylated HMO [93] Sialylated GOS [87] GD3 [50] Hyaluronan 35 kD [94] Protein/amino acid-based interventions L-Glutamine/glutamine [84,[95][96][97] Arginine [98,99] L-Carnitine [99] N-Acetylcysteine [85] Lactadherin [51] OPN [100] Lactoferrin [101] IAP [102,103] [104] HB-EGF [41,[58]…”
Section: Fat-based Interventionsmentioning
confidence: 99%
See 3 more Smart Citations